The Effect of Irisin as a Metabolic Regulator and Its Therapeutic Potential for Obesity
Obesity is a worldwide health problem due to the imbalance of energy intake and energy expenditure. Irisin, a newly identified exercise-responsive myokine, which is produced by the proteolytic cleavage of fibronectin type III domain-containing protein 5 (FNDC5), has emerged as a promising therapeuti...
Saved in:
Main Authors: | Hui Li, Fang Wang, Mu Yang, Jiao Sun, Yi Zhao, Dongqi Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2021/6572342 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating Irisin Levels Are Not Regulated by Nutritional Status, Obesity, or Leptin Levels in Rodents
by: Mar Quiñones, et al.
Published: (2015-01-01) -
Irisin Exerts Neuroprotective Effects on Cultured Neurons by Regulating Astrocytes
by: Kexin Wang, et al.
Published: (2018-01-01) -
Regulation of adipocyte differentiation and lipid metabolism by novel synthetic chromenes exploring anti-obesity and broader therapeutic potential
by: Kewalin Inthanon, et al.
Published: (2025-02-01) -
Irisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseases
by: Pei Wen, et al.
Published: (2025-02-01) -
Metabolic Profile in a Cohort of Young Sicilian Patients with Klinefelter’s Syndrome: The Role of Irisin
by: Stefano Radellini, et al.
Published: (2022-01-01)